✦ LIBER ✦

New drugs for rheumatoid arthritis: The industry point of view

✍ Scribed by Stephen H. Polmar

Book ID: 119358070
Publisher: Elsevier Science
Year: 2010
Tongue: Spanish
Weight: 100 KB
Volume: 6
Category: Article
ISSN: 2173-5743
DOI: 10.1016/j.reuma.2009.10.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

New drugs for rheumatoid arthritis: The

New drugs for rheumatoid arthritis: The industry point of view

✍ Stephen H. Polmar 📂 Article 📅 2010 🏛 Elsevier Science 🌐 Spanish ⚖ 171 KB

NICE and new drugs for rheumatoid arthri

NICE and new drugs for rheumatoid arthritis

✍ The Lancet 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 44 KB

Guidelines for the drug treatment of rhe

Guidelines for the drug treatment of rheumatoid arthritis

✍ da Mota, Licia Maria Henrique; Cruz, Bóris Afonso; Brenol, Claiton Viegas; Perei 📂 Article 📅 2013 🏛 Springer (Biomed Central Ltd.) 🌐 Portuguese ⚖ 310 KB

Emerging biologic drugs for the treatmen

Emerging biologic drugs for the treatment of rheumatoid arthritis

✍ Francesco Puppo; Giuseppe Murdaca; Massimo Ghio; Francesco Indiveri 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 95 KB

Systematic Review of Tofacitinib: A New

Systematic Review of Tofacitinib: A New Drug for the Management of Rheumatoid Arthritis

✍ Kaur, Kirandeep; Kalra, Sonesh; Kaushal, Sandeep 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 313 KB

The total costs of drug therapy for rheu

The total costs of drug therapy for rheumatoid arthritis

✍ Mark J. Prashker; Robert F. Meenan 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 779 KB

We created a model to estimate the total medication costs of treating patients with rheumatoid arthritis with 6 second-line agents for the first 6 months of treatment. Methods. Drug costs were obtained from a survey of pharmacies; monitoring costs were calculated from utilization information obtain